(Q47689004)

4 February 2018

title

Controlled inhalation of aerosolised therapeutics. (English)

1 reference

4 February 2018

author name string

William D Bennett

series ordinal

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 July 2005

1 reference

4 February 2018

Expert Opinion on Drug Delivery

published in

1 reference

4 February 2018

volume

2

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

763-767

1 reference

4 February 2018

Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Targeting delivery of aerosols to different lung regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Variability of fine particle deposition in healthy adults: effect of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Adaptive Aerosol Delivery (AAD) technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Gene therapy for the respiratory manifestations of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.4.763

21 January 2018

Identifiers

DOI

10.1517/17425247.2.4.763

1 reference

4 February 2018

PubMed ID

16296800

1 reference

4 February 2018